GAP-43 has been implicated in presynaptic vesicle cycling and its expression and serum levels are upregulated in hyperexcitatory conditions such as epilepsy14,35 and GAP-43 CSF levels increase in AD already at preclinical stages18,25. This evidence concerns the gene GAP43 and Alzheimer disease.